CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes

Files

CVOT Summit 2022 Report new cardiovascular, kidney, and glycemic outcomes.pdf (797.77 KB)

Date

Authors

Schnell, Oliver

Battelino, Tadej

Bergenstal, Richard

Birkenfeld, Andreas L.

Ceriello, Antonio

Davies, Melanie

Giorgino, Francesco

dc.identifier.doi

10.1186/s12933-023-01788-6

dc.identifier.other

WOS:000954649400001

Publisher

BMC

DOI

10.1186/s12933-023-01788-6

Keywords

Cardiovascular disease , Chronic kidney disease , Diabetes , GIP , GLP\\-1 receptor agonist , Heart failure , Obesity , SGLT2 inhibitor

URI

https://openaccess.acibadem.edu.tr/handle/11443/6529

Collections